Press release
Moderate Psoriasis Market is projected to reach USD 16.21 billion by 2034
Moderate Psoriasis
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71341
Moderate psoriasis represents a large subpopulation of psoriasis patients who experience more extensive skin involvement than mild cases but do not necessarily qualify for the most intensive biologic therapy regimens used in severe disease. However, moderate psoriasis is increasingly recognized as systemic, often associated with comorbidities such as psoriatic arthritis, cardiovascular risk, metabolic syndrome, anxiety, and depression.
Because moderate psoriasis is highly visible, physically uncomfortable, and psychologically distressing, treatment demand is strong and growing.
Key Market Highlights
• 2024 Market Size: USD 7.94 billion
• 2034 Forecast: USD 16.21 billion
• CAGR (2025-2034): 7.5%
• Largest Therapy Class: Biologics (IL-17, IL-23 inhibitors)
• Fastest-Growing Segment: Oral targeted therapies (PDE4 & JAK inhibitors)
Epidemiology & Patient Pool Insights
1. Psoriasis Global Burden
Psoriasis affects 125+ million people worldwide, with moderate disease accounting for:
• 20-35% of all psoriasis cases.
2. Disease Assessment Metrics
Moderate psoriasis typically involves:
• Psoriasis Area and Severity Index (PASI) score: 6-12
• Body Surface Area (BSA): 3-10%
• Dermatology Life Quality Index (DLQI): moderate impairment
3. Comorbidities Increasing Disease Burden
Moderate psoriasis is highly associated with:
• Obesity
• Type 2 diabetes
• Dyslipidemia
• Cardiovascular diseases
• Psoriatic arthritis
• Anxiety & depression
4. Diagnosis & Awareness Improving
Dermatology societies are intensifying outreach, leading to more patients being classified into moderate severity categories.
Market Growth Drivers
1. Widespread Adoption of Biologic Therapies
Biologics targeting IL-17, IL-23, and TNF pathways offer:
• Rapid skin clearance
• Durable remission
• Better quality of life
They are increasingly used earlier in disease progression.
2. Rise of Oral Targeted Therapies
PDE4 inhibitors and JAK inhibitors provide effective alternatives for patients unwilling or unable to use injectables.
3. Improved Access to Dermatology Specialists
Urbanization and teledermatology growth allow more patients to seek treatment earlier.
4. Large Untreated Patient Base
Millions of moderate psoriasis patients rely only on topical therapies but are eligible for systemic treatments.
5. Increasing Focus on Patient-Reported Outcomes
Moderate disease significantly affects:
• Self-image
• Sleep
• Work productivity
• Overall mental health
This drives demand for effective interventions.
Market Restraints
• High cost of biologic and targeted therapies
• Safety concerns with long-term immunosuppression
• Insurance limitations or step-therapy requirements
• Underdiagnosis in low-income countries
Market Opportunities
1. Expansion of IL-23 Inhibitors
IL-23 inhibitors show strong long-term skin clearance, driving adoption in moderate disease segments.
2. Growth in Topical Innovation
Non-steroidal topicals, combination formulations, and novel delivery systems bring new opportunities.
3. Personalized Dermatology
Genetic markers and cytokine profiling are paving the way for patient-specific therapy choices.
4. Digital Dermatology Tools
AI-powered skin severity scoring improves treatment decisions and monitoring.
5. Microbiome and Regenerative Approaches
Emerging research on skin-gut immune interactions may lead to next-generation therapies.
Segmentation Overview
By Treatment Type
• Topical therapies
• Phototherapy
• Systemic therapies
• Biologics (IL-17, IL-23, TNF inhibitors)
• Oral targeted therapies (PDE4, JAK inhibitors)
By Route of Administration
• Topical
• Oral
• Injectable
By Patient Demographics
• Adult
• Pediatric/Adolescent
By End User
• Hospitals
• Dermatology clinics
• Retail & online pharmacies
• Specialty treatment centers
Explore Full Report here: https://exactitudeconsultancy.com/reports/71341/moderate-psoriasis-market
Regional Insights
North America - Largest Market
High biologic utilization, strong insurance coverage, and increasing awareness of moderate disease classification.
Europe - Structured Clinical Guidelines
NICE, EADV, and national care pathways support moderate psoriasis management.
Asia Pacific - Fastest Growing Market
Large population base, increasing pollution-related skin disorders, and improving dermatology access.
Latin America - Growing Adoption of Systemic Therapies
Economic improvements and urbanization expand access.
Middle East & Africa - Emerging Market
Limited dermatology capacity but growing due to improved healthcare investments.
Competitive Landscape
Major companies active in moderate psoriasis therapeutics include:
• Novartis
• Eli Lilly
• AbbVie
• Amgen
• Johnson & Johnson
• Pfizer
• UCB Pharma
• Bristol Myers Squibb
• Sun Pharma
• LEO Pharma
Their portfolios include biologics, targeted oral drugs, advanced topicals, and biosimilars.
Recent Market Developments
• IL-23 inhibitors demonstrating sustained skin clearance over multiple years
• Expansion of JAK inhibitors into moderate psoriasis cases
• AI-powered PASI scoring tools entering dermatology clinics
• Biosimilars improving affordability of biologics
• New fixed-dose combination topicals gaining adoption
Future Outlook (2025-2034)
The Moderate Psoriasis Market is expected to expand steadily as:
• Biologics continue to dominate treatment standards
• Oral targeted therapies reshape systemic therapy preferences
• Digital assessment tools improve monitoring accuracy
• New formulations and delivery systems enhance patient adherence
• Personalized therapy becomes mainstream in dermatology
By 2034, the market is projected to reach USD 16.21 billion, supported by continuous therapeutic innovation and rising global psoriasis burden.
This report is also available in the following languages : Japanese (中等度乾癬市場), Korean (중등도 건선 시장), Chinese (中度银屑病市场), French (Marché modéré du psoriasis), German (Markt für mittelschwere Psoriasis), and Italian (Mercato della psoriasi moderata), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/request-sample/71341
Our More Reports:
Phototherapies for Psoriasis Market
https://exactitudeconsultancy.com/reports/71430/phototherapies-for-psoriasis-market
Moderate to Severe Plaque Psoriasis Market
https://exactitudeconsultancy.com/reports/71342/moderate-to-severe-plaque-psoriasis-market
Moderate to Severe Psoriasis Market
https://exactitudeconsultancy.com/reports/71343/moderate-to-severe-psoriasis-market
Moderate to Severe Atopic Dermatitis Market
https://exactitudeconsultancy.com/reports/71367/moderate-to-severe-atopic-dermatitis-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Moderate Psoriasis Market is projected to reach USD 16.21 billion by 2034 here
News-ID: 4309529 • Views: …
More Releases from Exactitude Consultancy
Metastatic HER2-Positive Breast Cancer - Patient Pool Analysis Market Trades 203 …
Market Overview
The Metastatic HER2-Positive Breast Cancer Patient Pool Analysis Market is expanding as global incidence rates continue to rise and treatment advances improve survival outcomes. HER2-positive breast cancer accounts for a significant portion of metastatic breast cancer cases and is known for its aggressive progression.
With improvements in diagnostics, biomarker testing, and early screening programs, the number of identified HER2-positive cases is increasing worldwide. The emphasis on understanding patient population characteristics-such…
Glioma Market Growth Opportunities 2025-2034
Market Overview
The Glioma Market is witnessing steady growth as new therapeutic approaches continue to emerge for one of the most aggressive and complex forms of brain tumors. Gliomas originate in glial cells and represent the majority of malignant brain cancers. The increasing global incidence of glioblastoma and other high-grade gliomas, combined with rising awareness, improved diagnostic capability, and expanded research in precision oncology, is driving market demand. Novel immunotherapies, targeted…
Juvenile Rheumatoid Arthritis (JRA) Market is projected to reach USD 4.72 billio …
The global Juvenile Rheumatoid Arthritis (JRA) Market was valued at USD 2.31 billion in 2024 and is projected to reach USD 4.72 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2025-2034). Growth is driven by rising pediatric autoimmune disease prevalence, increasing access to biologics, better early diagnosis through pediatric rheumatology programs, and expanding use of advanced targeted therapies to control inflammation and prevent long-term joint…
Pediatric Relapsed & Refractory Neuroblastoma Market Trades 2034
Market Overview
The Pediatric Relapsed and Refractory Neuroblastoma Market is expanding as unmet needs remain high for children who fail first-line therapy or experience disease recurrence. Neuroblastoma, a rare pediatric cancer originating in nerve tissues, poses significant treatment challenges when it becomes resistant or relapses after conventional chemotherapy, surgery, and radiation. As a result, demand for novel immunotherapies, targeted biologics, CAR-T therapies, and precision medicine is accelerating globally. Improved survival outcomes,…
More Releases for Moderate
Synchronous Condenser Market Set for Moderate Growth by 2030
According to a new report published by Allied Market Research, The synchronous condenser market size was valued at $568.9 million in 2020, and is projected to reach $751 million by 2030, growing at a CAGR of 2.8% from 2021 to 2030.
Synchronous condenser is the device used to generate or absorb reactive power as per the need for stabilization of electric utilities. It is an alternative to capacitor bank to correct…
Tin Market Outlook: Moderate Growth Projected Through 2032
Tin Market size was valued at 282.52 Kilotonin 2024 and the total Tin revenue is expected to grow at a CAGR of 2.1% from 2025 to 2032, reaching nearly 333.63 Kiloton.
Tin Market Overview:
The tin market is witnessing consistent growth due to its critical applications across several industries. Tin is most commonly used in soldering, particularly within the electronics industry, which continues to expand with the rise of consumer electronics, renewable…
Biocides Market Forecast Shows Moderate but Consistent Growth
Biocides market is expected to reach US$ 16.07 Bn. in 2030 from US$ 12.30 Bn. in 2023, with a CAGR of 3.9% for the period 2024-2030.
Biocides Market Overview:
The biocides market is experiencing steady growth, driven by increasing demand across various industries such as water treatment, healthcare, agriculture, and consumer goods. Biocides, which are chemical or biological agents that control harmful organisms, play a crucial role in ensuring hygiene, preserving materials,…
Dutch Mendenhall to Moderate Athletes in Business Panel
Las Vegas, NV - July 9, 2024 - Dutch Mendenhall [https://www.linkedin.com/in/dutchmendenhall], the esteemed owner of Wentworth Golf Club [https://wentworthgolfclub.org/], best-selling author of Money Shackles, and former Division 1 volunteer coach, will moderate the "Athletes in Business" panel at The Palms Las Vegas on Sunday, July 14, 2024. This event will bring together some of the most influential athletes turned business professionals to share their insights and experiences.
Dutch Mendenhall's diverse background…
Planter Market will reflect a relatively moderate growth in demand
Planter is a container used for planting flowers, and different types of small plants. It can be of plastic, wood, ceramics, and glass. Planters are of different sizes, shapes, and colors. These are mostly used for decoration, nurseries, and greenhouses for both interior as well as exterior decoration. These help enhance the appearance of the property. The use of planter in decoration in hotels, rental houses can attract the customer.
…
Mild-to-Moderate Atopic Dermatitis Treatment Market: Lucrative Opportunities
Mild-to-moderate atopic dermatitis is a chronic inflammatory skin disease often localized to the flexural surfaces of the body and usually begins in childhood. This skin disease affects a large percentage of the world's population. Atopic dermatitis, commonly known as eczema, is characterized by dry skin, itching, redness, swelling, vesicle formation, cracking, weeping, crusting, and scaling. Atopic dermatitis is a long-term skin disease, which is classified into different types depending on…
